{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:58:55Z","timestamp":1766516335942,"version":"3.40.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["$16 373 368","$19 436 549"],"award-info":[{"award-number":["$16 373 368","$19 436 549"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","valueinhealthjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jval.2024.01.013","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T16:33:12Z","timestamp":1706891592000},"page":"614-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study"],"prefix":"10.1016","volume":"27","author":[{"given":"Lori","family":"McLeod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Ervin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheri E.","family":"Fehnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonya","family":"Eremenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn T.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Joel","family":"Coons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jval.2024.01.013_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/clpt.2011.203","article-title":"The Patient-Reported Outcome (PRO) Consortium: filling measurement gaps for PRO endpoints to support labeling claims","volume":"90","author":"Coons","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jval.2024.01.013_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1574887111308010003","article-title":"Clinical trials in irritable bowel syndrome: a review","volume":"8","author":"Ervin","year":"2013","journal-title":"Rev Recent Clin Trials"},{"issue":"4","key":"10.1016\/j.jval.2024.01.013_bib6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jval.2016.11.001","article-title":"Development of the diary for irritable bowel syndrome symptoms to assess treatment benefit in clinical trials: foundational qualitative research","volume":"20","author":"Fehnel","year":"2017","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jval.2024.01.013_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jval.2020.01.002","article-title":"Psychometric analysis of the abdominal score from the diary for irritable bowel syndrome symptoms-constipation using phase iib clinical trial data","volume":"23","author":"Coon","year":"2020","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2024.01.013_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00004836-199407000-00008","article-title":"An office guide to whole-gut transit time \u2013 patients\u2019 recollection of their stool form","volume":"19","author":"Heaton","year":"1994","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"9","key":"10.1016\/j.jval.2024.01.013_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/00365520310004209","article-title":"An irritable bowel syndrome-specific symptom questionnaire: development and validation","volume":"38","author":"Wiklund","year":"2003","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jval.2024.01.013_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jval.2024.01.013_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1037\/0033-2909.86.2.420","article-title":"Intraclass correlations: uses in assessing rater reliability","volume":"86","author":"Shrout","year":"1979","journal-title":"Psychol Bull"},{"issue":"1","key":"10.1016\/j.jval.2024.01.013_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1037\/1082-989X.1.1.30","article-title":"Forming inferences about some intraclass correlation coefficients","volume":"1","author":"McGraw","year":"1996","journal-title":"Psychol Methods"},{"issue":"4","key":"10.1016\/j.jval.2024.01.013_bib14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s11136-018-2076-0","article-title":"Assessing test-retest reliability of patient-reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula","volume":"28","author":"Qin","year":"2019","journal-title":"Qual Life Res"},{"year":"1994","series-title":"Psychometric Theory","author":"Nunnally","key":"10.1016\/j.jval.2024.01.013_bib15"},{"year":"2016","series-title":"IBS Working Group advice \u2013 information request","key":"10.1016\/j.jval.2024.01.013_bib16"},{"year":"2003","series-title":"Applied Statistics for the Behavioral Science","author":"Hinkle","key":"10.1016\/j.jval.2024.01.013_bib17"},{"issue":"11","key":"10.1016\/j.jval.2024.01.013_bib18","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/ajg.2012.255","article-title":"A\u00a012-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation","volume":"107","author":"Rao","year":"2012","journal-title":"Am J Gastroenterol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301524000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301524000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:48:28Z","timestamp":1746103708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301524000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1098301524000421"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2024.01.013","relation":{},"ISSN":["1098-3015"],"issn-type":[{"type":"print","value":"1098-3015"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2024.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}